Update on Clinical Trials in Systemic Lupus Erythematosus

Sonali Narain; Richard Furie

Disclosures

Curr Opin Rheumatol. 2016;28(5):477-487. 

In This Article

Conclusion

Despite inherent obstacles, there is unprecedented enthusiasm for a disease with great unmet need. It is incumbent upon the lupus community to understand the reasons for failed trials, to better elucidate the immunopathogenesis of SLE and to move forward with lessons learned from the past. There is no doubt that safer and more effective drugs will be introduced in the years to come.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....